Company Filing History:
Years Active: 2012-2017
Title: The Innovations of Eugene Joseph Vidunas
Introduction
Eugene Joseph Vidunas is a notable inventor based in Middletown, NY (US). He has made significant contributions to the field of biotechnology, holding a total of 5 patents. His work primarily focuses on immunogenic compositions and cytotoxic drug conjugates, which have important implications in medical treatments.
Latest Patents
One of his latest patents involves immunogenic fusion polypeptides. This invention relates to an isolated polypeptide that includes the amino acid sequence of a carrier polypeptide and the amino acid sequence of an ORF2086 polypeptide. Additionally, it encompasses an immunogenic conjugate that includes the ORF2086 polypeptide and a carrier polypeptide. The invention also includes immunogenic compositions and methods for inducing an immune response in mammals. Another significant patent is for calicheamicin derivative-carrier conjugates. This patent describes methods for preparing monomeric cytotoxic drug/carrier conjugates with a drug loading significantly higher than previously reported procedures, while also reducing aggregation and low conjugate fraction (LCF). It further details cytotoxic drug derivative/antibody conjugates, compositions comprising these conjugates, and their uses.
Career Highlights
Eugene has worked with prominent companies in the pharmaceutical industry, including Wyeth Holdings Corporation and Pfizer Corporation. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in drug delivery systems and immunotherapy.
Collaborations
Throughout his career, Eugene has collaborated with talented individuals such as Justin Keith Moran and Mark Edward Ruppen. These partnerships have fostered a creative environment that has led to the development of groundbreaking inventions.
Conclusion
Eugene Joseph Vidunas is a distinguished inventor whose work in biotechnology has led to several important patents. His contributions to immunogenic compositions and cytotoxic drug conjugates continue to influence the field and hold promise for future medical advancements.